[KLK] YoY TTM Result on 31-Mar-2019 [#2]

Announcement Date
15-May-2019
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2019
Quarter
31-Mar-2019 [#2]
Profit Trend
QoQ- -6.78%
YoY- -26.31%
View:
Show?
TTM Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 24,318,710 16,523,070 15,388,197 16,549,789 19,914,758 19,432,520 15,510,765 7.77%
PBT 3,571,693 1,966,556 653,820 919,371 1,312,679 1,426,282 1,697,723 13.19%
Tax -757,564 -395,883 -214,024 -241,136 -374,059 -81,572 -250,562 20.23%
NP 2,814,129 1,570,673 439,796 678,235 938,620 1,344,710 1,447,161 11.71%
-
NP to SH 2,555,631 1,425,360 418,725 637,299 864,785 1,278,694 1,396,914 10.58%
-
Tax Rate 21.21% 20.13% 32.73% 26.23% 28.50% 5.72% 14.76% -
Total Cost 21,504,581 14,952,397 14,948,401 15,871,554 18,976,138 18,087,810 14,063,604 7.33%
-
Net Worth 13,238,141 11,421,586 10,190,779 10,628,357 11,075,642 11,448,381 9,808,334 5.12%
Dividend
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Div 215,604 215,705 160,569 159,744 532,482 532,482 479,234 -12.45%
Div Payout % 8.44% 15.13% 38.35% 25.07% 61.57% 41.64% 34.31% -
Equity
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Net Worth 13,238,141 11,421,586 10,190,779 10,628,357 11,075,642 11,448,381 9,808,334 5.12%
NOSH 1,081,017 1,081,017 1,081,017 1,064,965 1,064,965 1,064,965 1,064,965 0.24%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 11.57% 9.51% 2.86% 4.10% 4.71% 6.92% 9.33% -
ROE 19.31% 12.48% 4.11% 6.00% 7.81% 11.17% 14.24% -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
RPS 2,255.86 1,532.01 1,437.53 1,554.02 1,869.99 1,824.71 1,456.46 7.56%
EPS 237.07 132.16 39.12 59.84 81.20 120.07 131.17 10.36%
DPS 20.00 20.00 15.00 15.00 50.00 50.00 45.00 -12.63%
NAPS 12.28 10.59 9.52 9.98 10.40 10.75 9.21 4.90%
Adjusted Per Share Value based on latest NOSH - 1,064,965
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
RPS 2,212.83 1,503.48 1,400.22 1,505.91 1,812.10 1,768.22 1,411.37 7.77%
EPS 232.54 129.70 38.10 57.99 78.69 116.35 127.11 10.58%
DPS 19.62 19.63 14.61 14.54 48.45 48.45 43.61 -12.45%
NAPS 12.0458 10.3928 9.2729 9.6711 10.078 10.4172 8.9249 5.12%
Price Multiplier on Financial Quarter End Date
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Date 31/03/22 31/03/21 31/03/20 29/03/19 30/03/18 31/03/17 31/03/16 -
Price 25.20 22.94 20.76 24.80 25.58 24.68 24.00 -
P/RPS 1.12 1.50 1.44 1.60 1.37 1.35 1.65 -6.25%
P/EPS 10.63 17.36 53.07 41.44 31.50 20.55 18.30 -8.65%
EY 9.41 5.76 1.88 2.41 3.17 4.87 5.47 9.45%
DY 0.79 0.87 0.72 0.60 1.95 2.03 1.87 -13.37%
P/NAPS 2.05 2.17 2.18 2.48 2.46 2.30 2.61 -3.94%
Price Multiplier on Announcement Date
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Date 24/05/22 19/05/21 27/05/20 15/05/19 16/05/18 22/05/17 16/05/16 -
Price 25.90 22.02 21.84 24.40 25.40 24.84 23.10 -
P/RPS 1.15 1.44 1.52 1.57 1.36 1.36 1.59 -5.25%
P/EPS 10.93 16.66 55.83 40.77 31.28 20.69 17.61 -7.63%
EY 9.15 6.00 1.79 2.45 3.20 4.83 5.68 8.26%
DY 0.77 0.91 0.69 0.61 1.97 2.01 1.95 -14.34%
P/NAPS 2.11 2.08 2.29 2.44 2.44 2.31 2.51 -2.85%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment